Literature DB >> 2002025

Assembly and secretion of recombinant human fibrinogen.

S N Roy1, R Procyk, B J Kudryk, C M Redman.   

Abstract

Expression vectors containing full-length cDNAs for each of the human fibrinogen chains were constructed. COS-1 cells were transfected with single vectors, mixtures of two, or with all three vectors and stable cell lines selected. Cells transfected with single vectors, or with mixtures of any two vectors, expressed the appropriate fibrinogen chains but did not secrete them. COS cells transfected with three vectors expressed all of the chains and secreted fibrinogen. COS cells transfected with three vectors contained, intracellularly, a mixture of fibrinogen-related proteins. The four main intracellular products were nascent fibrinogen, an A alpha.gamma complex, free A alpha chains, and free gamma chains. This is a similar pattern to that noted in Hep G2 cells. The intracellular forms of fibrinogen were sensitive to endoglycosidase H, indicating that they reside in a pre-Golgi compartment. Secreted fibrinogen was endoglycosidase H-insensitive, suggesting that the secreted glycoprotein moieties were processed in the normal manner. When mixed with plasma fibrinogen, radiolabeled recombinant fibrinogen was incorporated into a thrombin-induced clot. These studies demonstrate that COS cells transfected with all three fibrinogen chain cDNAs are capable of assembling and secreting a functional fibrinogen molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002025

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Secretion of recombinant human fibrinogen by the murine mammary gland.

Authors:  Stephen P Butler; Tanya K O'Sickey; Susan T Lord; Henryk Lubon; Francis C Gwazdauskas; William H Velander
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

2.  Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions.

Authors:  B S Coller; K T Springer; J H Beer; N Mohandas; L E Scudder; K J Norton; S M West
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Fib420: a normal human variant of fibrinogen with two extended alpha chains.

Authors:  Y Fu; G Grieninger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.